The latest addition to the list of genes that are involved in NAFLD, based on GWAS studies, was HSD17B13, a liver-specific enzyme that regulates lipid homeostasis. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.